Department of Hematology and Hematopoietic Cell Transplantation, City of Hope Comprehensive Cancer Center, Duarte, California 91010, USA.
Oncologist. 2011;16(11):1572-81. doi: 10.1634/theoncologist.2011-0214. Epub 2011 Oct 31.
The U.S. population is aging, life expectancy is increasing, and cancer is a disease associated with aging. Advances in screening and therapeutics have led to a growing number of cancer survivors who are at risk for the development of secondary malignancies. Although the risks for the development of second malignancies following a first diagnosis of cancer are well described for survivors of childhood malignancies, there are fewer data for malignancies common in older adults. With the aging of the U.S. population, and with improving survival statistics in many adult malignancies, there is an increasing need to identify those second malignancies that might develop in the older adult survivor of cancer. In this paper, we describe the types and rates of second malignancies following cancers commonly seen in older adults and review the literature on these malignancies. Comparisons are made between older and younger adults with regard to the risks for developing treatment-related cancers with different modalities. Recommendations for early detection of second malignancies are summarized, though there remains an unmet need for evidence-based guidelines for screening for second malignancies in the older adult in particular.
美国人口老龄化,预期寿命延长,癌症是一种与衰老相关的疾病。筛查和治疗的进步导致越来越多的癌症幸存者面临继发恶性肿瘤的风险。尽管儿童期恶性肿瘤幸存者首次诊断后发生第二恶性肿瘤的风险已有详细描述,但老年人常见恶性肿瘤的数据较少。随着美国人口老龄化以及许多成人恶性肿瘤的生存统计数据改善,越来越需要识别可能在癌症老年幸存者中发展的第二恶性肿瘤。在本文中,我们描述了老年人中常见癌症后的第二恶性肿瘤的类型和发生率,并回顾了这些恶性肿瘤的文献。就不同治疗方式相关癌症的发病风险而言,比较了老年人和年轻人。总结了第二恶性肿瘤早期检测的建议,但特别在老年人群中,仍需要基于证据的第二恶性肿瘤筛查指南。